Surgeon's and Patient Examination Gloves; Reclassification
FDA proposes reclassifying surgeon's and patient examination gloves from Class I to Class II, requiring stricter controls like special labeling and performance standards. This directly impacts cosmetics/personal care businesses that manufacture or distribute such gloves as part of their product lines.
Aforeworn detected this change in the Cosmetics & Personal-Care (MoCRA) space on July 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Indie beauty brands, contract manufacturers, private-label makers, and importers/distributors that produce or sell surgeon's or patient examination gloves under MoCRA or FDA jurisdiction. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Proposed rule; final rule effective date not yet set. Monitor Federal Register for final rule and compliance dates.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Cosmetics & Personal-Care (MoCRA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Gloves will be reclassified from Class I (general controls) to Class II (special controls), requiring additional compliance measures such as performance testing, labeling changes, and possible premarket notification (510(k)).
Who it affects
Indie beauty brands, contract manufacturers, private-label makers, and importers/distributors that produce or sell surgeon's or patient examination gloves under MoCRA or FDA jurisdiction.
What you must do
Review current glove products to determine if they fall under the proposed reclassification; prepare for potential 510(k) submissions or updated labeling.
Deadline
Proposed rule; final rule effective date not yet set. Monitor Federal Register for final rule and compliance dates.
Never miss a change like this again
Aforeworn watches Cosmetics & Personal-Care (MoCRA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Cosmetics & Personal-Care (MoCRA)
- FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
- FDA Grants Seventh Approval under the National Priority Voucher Pilot Program
- FDA Issues Guidance to Improve Collection of Pregnancy Safety Data for Drugs and Biologics
- FDA Expands AI Capabilities and Completes Data Platform Consolidation
- FDA Approves First Treatment for Chronic Hepatitis Delta Virus (HDV) Infection